​

LivaNova (LIVN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LIVN Stock Forecast

LivaNova (LIVN) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $56.00, with a high of $56.00 and a low of $56.00. This represents a 20.09% increase from the last price of $46.63.

$45 $49 $53 $57 $61 $65 High: $56 Avg: $56 Low: $56 Last Closed Price: $46.63

LIVN Stock Rating

LivaNova stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (76.92%), 2 Hold (15.38%), 1 Sell (7.69%), and 0 Strong Sell (0.00%).

Buy
Total 13 1 2 10 0 Strong Sell Sell Hold Buy Strong Buy

LIVN Price Target Upside V Benchmarks

TypeNameUpside
StockLivaNova20.09%
SectorHealthcare Stocks 23.68%
IndustryMedical Device Stocks16.34%

Price Target Trends

1M3M12M
# Anlaysts--5
Avg Price Target--$65.80
Last Closing Price$46.63$46.63$46.63
Upside/Downside--41.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25452--11
May, 25443--11
Apr, 25443--11
Mar, 25344--11
Feb, 25353--11
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 07, 2025Barclays$56.00$39.1742.97%20.09%
Oct 31, 2024Anthony PetroneMizuho Securities$70.00$51.0537.12%50.12%
Oct 04, 2024David RomanGoldman Sachs$65.00$53.9020.59%39.40%
Sep 17, 2024David RescottRobert W. Baird$66.00$48.7935.27%41.54%
Jul 25, 2024Rick WiseStifel Nicolaus$72.00$53.4534.71%54.41%
Jun 06, 2024Rick WiseStifel Nicolaus$70.00$53.1631.68%50.12%
Mar 20, 2024Rick WiseStifel Nicolaus$65.00$56.6314.78%39.40%
Dec 21, 2022Barclays$62.00$56.0510.62%32.96%
Nov 23, 2022Goldman Sachs$63.00$53.9516.77%35.11%
Aug 16, 2022Goldman Sachs$73.00$63.8614.31%56.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 20, 2025Wolfe ResearchOutperformupgrade
Feb 21, 2024NeedhamBuyBuyhold
Feb 20, 2024Mizuho SecuritiesBuyupgrade
Oct 23, 2023NeedhamBuyBuyhold
Dec 21, 2022BarclaysEqual-Weightinitialise
Nov 23, 2022Goldman SachsBuyBuyhold
Aug 16, 2022Goldman SachsBuyBuyhold
Aug 04, 2022NeedhamBuyBuyhold
Feb 24, 2022NeedhamBuyBuyhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.06$-2.68$-1.61$0.33$1.17----
Avg Forecast$1.23$2.08$2.32$2.71$3.37$3.66$4.00$4.53$4.96
High Forecast$1.24$2.11$2.37$2.77$3.40$3.75$5.10$4.61$5.05
Low Forecast$1.22$2.06$2.19$2.67$3.35$3.57$2.64$4.31$4.72
Surprise %-673.98%-228.85%-169.40%-87.82%-65.28%----

Revenue Forecast

$900M $1B $1B $1B $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$934.20M$1.04B$1.02B$1.15B$1.25B----
Avg Forecast$933.39M$1.03B$1.01B$1.13B$1.26B$1.33B$1.40B$1.46B$1.55B
High Forecast$943.34M$1.04B$1.02B$1.14B$1.27B$1.34B$1.41B$1.48B$1.57B
Low Forecast$927.45M$1.03B$966.50M$1.09B$1.25B$1.32B$1.39B$1.44B$1.49B
Surprise %0.09%0.29%1.24%1.94%-0.23%----

Net Income Forecast

$-450M $-300M $-150M $0 $150M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-343.30M$-135.70M$-86.20M$17.55M$63.20M----
Avg Forecast$-342.95M$-76.67M$-14.42M$17.55M$182.88M$198.62M$209.82M$241.84M$268.89M
High Forecast$-255.83M$-61.34M$-3.91M$30.34M$184.24M$203.53M$276.57M$249.87M$273.59M
Low Forecast$-430.07M$-92.01M$-24.94M$4.75M$181.53M$193.71M$143.06M$233.81M$256.00M
Surprise %0.10%76.99%497.64%--65.44%----

LIVN Forecast FAQ

Is LivaNova stock a buy?

LivaNova stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that LivaNova is a favorable investment for most analysts.

What is LivaNova's price target?

LivaNova's price target, set by 13 Wall Street analysts, averages $56 over the next 12 months. The price target range spans from $56 at the low end to $56 at the high end, suggesting a potential 20.09% change from the previous closing price of $46.63.

How does LivaNova stock forecast compare to its benchmarks?

LivaNova's stock forecast shows a 20.09% upside, underperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the medical device stocks industry (16.34%).

What is the breakdown of analyst ratings for LivaNova over the past three months?

  • June 2025: 36.36% Strong Buy, 45.45% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 36.36% Strong Buy, 36.36% Buy, 27.27% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 36.36% Strong Buy, 36.36% Buy, 27.27% Hold, 0% Sell, 0% Strong Sell.

What is LivaNova’s EPS forecast?

LivaNova's average annual EPS forecast for its fiscal year ending in December 2025 is $3.66, marking a 212.82% increase from the reported $1.17 in 2024. Estimates for the following years are $4 in 2026, $4.53 in 2027, and $4.96 in 2028.

What is LivaNova’s revenue forecast?

LivaNova's average annual revenue forecast for its fiscal year ending in December 2025 is $1.33B, reflecting a 5.75% increase from the reported $1.25B in 2024. The forecast for 2026 is $1.4B, followed by $1.46B for 2027, and $1.55B for 2028.

What is LivaNova’s net income forecast?

LivaNova's net income forecast for the fiscal year ending in December 2025 stands at $198.62M, representing an 214.27% increase from the reported $63.2M in 2024. Projections indicate $209.82M in 2026, $241.84M in 2027, and $268.89M in 2028.